Keywords: 1st, qtr, net, income, up, ares-serono, swiss
1st qtr net income up 111% at Ares-Serono
Article | 30 April 1999
Swiss drugs group Ares-Serono reported a 93.2% rise in operating incomeand 111.3% in net earnings for the first quarter of 1999, to $56.3 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
